Endoscopic Submucosal Dissection for Esophageal Lesions in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational cohort collects data from patients treated with submucosal dissection for superficial esophageal neoplasms. It focuses on real-world outcomes after endoscopic resection, including factors that influence recurrence and potential spread. Data will come from routine clinical care at participating centers, with emphasis on histological features and safety. No experimental interventions are introduced beyond standard endoscopic practice. The study aims to describe patterns of care and short- to mid-term outcomes across the French centers involved.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults (≥ 18 years old)
* Patients referred for endoscopic resection of an esophageal lesion and treated by submucosal dissection
* Patients managed in one of the participating centers
* Patient who has received oral and written information about the study and has not objected to participation
* Patients covered by a social security or health insurance scheme.

Exclusion Criteria:

* Patient refusal after reading the information sheet
* Patient under legal protection (guardianship, curatorship, court-ordered protection)
* Inability to inform the patient due to cognitive impairment, language barrier, or medical emergency
* Patients previously included for another lesion in the same study
* Pregnant or breastfeeding women.
* Patient deprived of liberty.
* Patient currently enrolled in another clinical trial.

Where it's running

• CHU de Bordeaux - Hôpital Haut-Lévêque
  Bordeaux, France Recruiting
• CHU de Limoges - Hôpital Dupuytren 1
  Limoges, France Recruiting
• Hôpital Édouard Herriot
  Lyon, France Recruiting
• CHRU de Nancy - Hôpital Brabois
  Nancy, France Recruiting
• Jules Verne Clinic
  Nantes, France Recruiting
• CHU de Rennes - Hôpital Pontchaillou
  Rennes, France Recruiting

Study contacts

• Study coordinator: Bertrand BB BRIEAU, MD
• Email: bertrand.brieau@gmail.com
• Phone: +33650266383

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Breath test to help detect gastrointestinal cancers early

  A breath test that looks for signals in exhaled air to see if someone with gut cancer symptoms might have oesophageal, stomach, pancreatic, liver, or colorectal cancer and need urgent testing.

  Recruiting Imperial College London · Maidstone, Kent and 5 other locations · NCT07714538

• Ifinatamab deruxtecan for advanced esophageal squamous cell carcinoma

  This trial will test whether ifinatamab deruxtecan can shrink or eliminate advanced esophageal squamous cell carcinoma in people whose cancer progressed after one or two prior systemic treatments.

  Recruiting at 34 sites Phase 1/2 Merck Sharp & Dohme LLC · Pittsburgh, Pennsylvania and 33 other locations · NCT07405151

• Pre-treatment exercise to improve outcomes for people with oesophageal adenocarcinoma

  This trial will test whether a short programme of low- or high-intensity exercise before chemotherapy and surgery helps people with resectable oesophageal adenocarcinoma by increasing immune activity in tumours and improving recovery.

  Recruiting University of Surrey · Guildford, Surrey · NCT07375420

• Seismocardiography to gauge fitness and predict outcomes before esophageal cancer surgery

  A noninvasive seismocardiography device is tested to see if it can quickly estimate a patient’s fitness and help predict surgical outcomes for adults with esophageal cancer who are planning curative treatment.

  Recruiting at 3 sites Guy's and St Thomas' NHS Foundation Trust · Guildford and 3 other locations · NCT07159711

• Metformin before pre-surgery chemoradiotherapy to boost immune activity in oesophageal adenocarcinoma

  This trial will try two weeks of metformin before neoadjuvant chemoradiotherapy to see if it activates the tumour immune environment in adults with stage II–III oesophageal adenocarcinoma.

  Recruiting Phase 2 Amsterdam UMC, location VUmc · Amsterdam and 1 other locations · NCT06687876

• Assessing biomarkers after surgery for oesophagogastric cancer

  This study is trying to find out if certain biological markers in patients who had surgery for oesophageal and gastric cancer can help predict how well they will respond to treatment and their chances of recovery.

  Recruiting Imperial College London · London · NCT06289374

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.